Inaugural lecture by professor Clare Hawkins – University of Copenhagen

Forward this page to a friend Resize Print Bookmark and Share

English > News > Inaugural lecture by p...

31 May 2017

Inaugural lecture by professor Clare Hawkins

Inaugural lecture

Clare Hawkins has recently been appointed professor at the Department of Biomedical Sciences and in this connection an inaugural lecture will be held.

The Department would like to invite you to celebrate the appointment with an inaugural lecture by Professor Clare Hawkins entitled "Inflammation, Oxidation and Atherosclerosis"

The lecture will be held on 15 September 2017, at 14:30 in Dam Auditorium at Panum. After the lecture, there will be a reception in the Faculty Club.

Atherosclerosis is the major cause of cardiovascular disease
Cardiovascular diseases are the leading cause of death in the EU, and account for one quarter of all deaths in Denmark. The primary underlying cause of most cardiovascular disease is atherosclerosis - the abnormal build-up of cholesterol and fatty deposits within the arterial wall, which progresses over decades to form complex plaques and lesions that eventually lead to heart attacks and strokes. The incidence of atherosclerosis is increasing worldwide, owing to the epidemic of obesity, diabetes and associated metabolic disorders. Currently, the main treatment for atherosclerosis involves the use of statin drugs to lower patient cholesterol levels to slow the development of lesions. However, statins are not tolerated by all patients, and a significant cardiovascular risk remains, highlighting the need for the development of more effective therapies to treat atherosclerosis and reduce the incidence of cardiovascular disease.

Professor Clare Hawkins’ research is focused on understanding how chronic inflammation drives the development of atherosclerosis. Her primary interest concerns understanding how oxidants produced during inflammation modify the structure and function of biological molecules and cells associated with the arterial wall, as a means to develop more targeted therapies to prevent lesion formation and slow the progression of atherosclerosis. Clare relocated to Copenhagen after nearly 20 years in Sydney, Australia, at the Heart Research Institute, were she moved following the completion of her PhD in the Department of Chemistry, University of York, England in 1997. Clare is a former Australian Research Council Future Fellow and Principal Research Fellow within Sydney Medical School, University of Sydney. While in Australia, Clare held a number of other prestigious Career Fellowships and Project Grants from major Australian funding agencies, including the National Health and Medical Research Council and National Heart Foundation.